Wholesaler reports $100m in new pharmacy revenue

New wholesale business, TWC growth and accelerated sales of GLP-1 medicines bolster EBOS revenues   EBOS is reporting strong progress in its near-term growth strategies, with the company seeing $100 million in revenue from new pharmacy wholesale customers in the first half of its 2025 financial year.   Announcing its results for the six months